Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Abstract
Transfection of embryo fibroblasts by a human ras oncogene does not convert them into tumour cells unless the fibroblasts are established and immortalized before transfection. The embryo fibroblasts become tumorigenic if a second oncogene such as a viral or cellular myc gene or the gene for the polyoma large-T antigen is introduced together with the ras gene.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, transformation of primary cells by ras requires either a cooperating oncogene or the inactivation of tumor suppressors such as p53 or p16.”
From Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a (1997) · cites this paper as Land et al. 1983
In the citing paper
“ras cooperates, however, with certain other oncogenic alterations to transform primary rodent cells (Land et al. 1983; Ruley 1983), including overexpression of c-Myc, dominant negative p53, D-type cyclins, and Cdc25A and -B, and loss of p53, p16, or IRF-1”
From Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a (1997) · cites this paper as Land et al. 1983
In the citing paper
“In that setting, dysfunctional telomeres induced a strong cellular senescence phenotype in the emerging lymphomas resulting in potent suppression of lymphomagenesis.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [93]
Citations
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. C., & Croce, C. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7824 · Cited by 1,773
Mutation selection and the natural history of cancer
Cairns, J. (1975) · Nature · doi:10.1038/255197a0 · Cited by 1,582
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis
Hayward, W. S., Neel, B. G., & Astrin, S. M. (1981) · Nature · doi:10.1038/290475a0 · Cited by 1,567
Taub, R., Kirsch, I., Morton, C., Lenoir, G., Swan, D., Tronick, S., Aaronson, S., & Leder, P. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7837 · Cited by 1,422
Mechanism of activation of a human oncogene
Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R., Lowy, D. R., & Chang, E. H. (1982) · Nature · doi:10.1038/300143a0 · Cited by 1,393
Self-citationRuley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248
Mulligan, R. C., & Berg, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2072 · Cited by 982
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Self-citationDer, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
Research works printed but not linked: 9
- Berenblum, I. & Shubik, P. Br. J. Cancer 1, 388 (1947).
- Emmelot, P. & Scherer, E. Cancer Res. 37, 1702–1708 (1977).
- Crawford, B. D., Barrett, J. C. & Ts'o, P. O. P. Molec. cell. Biol. 3, 931–945 (1983). · doi:10.1128/mcb.3.5.931
- Murray, M. J. et al. Cell (in the press).
- Aaronson, S. A. & Todaro, G. J. J. Cell Biol. 72, 141–148 (1968).
- Perucho, M., Hanahan, D. & Wigler, M. Cell 22, 309–317 (1980). · DOI · Paper page
- Beard, J. W. in Viral Oncology (ed. Klein, G.) 55–88 (Raven, New York, 1980).
- Adams, J. M., Gerondakis, S., Webb, E., Corcoran, L. & Cory, S. Proc. natn. Acad. Sci. U.S.A. (in the press).
- Gross, L. Oncogenic viruses, 931 (Pergamon, Oxford, 1970).
Cited by
Items 301–400 of 1,010
Alevizopoulos, K. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5322 · Cited by 203
“In ras with immortalizing oncogenes, such as c-myc (Land et al., 1983).”
BackgroundPapillomaviruses and human cancer
Arends, M. J., Wyllie, A. H., & Bird, C. C. (1990) · Human Pathology · doi:10.1016/0046-8177(90)90027-3 · Cited by 200
DNA-bound Fos proteins activate transcription in yeast
Lech, K., Anderson, K., & Brent, R. (1988) · Cell · doi:10.1016/0092-8674(88)90506-5 · Cited by 207
“…products (here called Fos and Myc proteins) is that overexpression of either of them in normal rat fibroblasts, together with expression of the activated ras oncogene product, transforms the cells and endows them with the ability to form tumors in living animals (Land et al., 1983; Ruley, 1983).”
Single-chromosome Gains Commonly Function as Tumor Suppressors
Sheltzer, J. M., Ko, J. H., Replogle, J. M., Habibe Burgos, N. C., Chung, E. S., Meehl, C. M., Sayles, N. M., Passerini, V., Storchova, Z., & Amon, A. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.12.004 · Cited by 201
“Complete transformation of rodent cells requires transduction with two cooperating oncogenes (Land et al., 1983).”
BackgroundSafety Issues Related to Retroviral-Mediated Gene Transfer in Humans
Cornetta, K., Morgan, R. A., & Anderson, W. F. (1991) · Human Gene Therapy · doi:10.1089/hum.1991.2.1-5 · Cited by 203
Specific growth response of ras-transformed embryo fibroblasts to tumour promoters
Paolo Dotto, G., Parada, L. F., & Weinberg, R. A. (1985) · Nature · doi:10.1038/318472a0 · Cited by 204
Self-citationRegulated transcription of c-Ki-ras and c-myc during compensatory growth of rat liver.
Goyette, M., Petropoulos, C. J., Shank, P. R., & Fausto, N. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.8.1493 · Cited by 201
Goetzman, E. S., & Prochownik, E. V. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00129 · Cited by 199
Schoenenberger, C. A., Andres, A. C., Groner, B., van der Valk, M., LeMeur, M., & Gerlinger, P. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02797.x · Cited by 198
Kamata, T., & Feramisco, J. R. (1984) · Nature · doi:10.1038/310147a0 · Cited by 199
Pfeifer-Ohlsson, S., Scott Goustin, A., Rydnert, J., Wahlström, T., Bjersing, L., Stehelin, D., & Ohlsson, R. (1984) · Cell · doi:10.1016/0092-8674(84)90513-0 · Cited by 204
The enigmatic protein kinase Cδ: complex roles in cell proliferation and survival
Jackson, D. N., & Foster, D. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0979rev · Cited by 195
“postulated by Weinberg and colleagues (78).”
(2001) · Advances in Clinical Chemistry · doi:10.1016/s0065-2423(01)35014-x · Cited by 194
[40] Biological assays for Ras transformation
Clark, G. J., Cox, A. D., Graham, S. M., & Der, C. J. (1995) · Methods in Enzymology · doi:10.1016/s0076-6879(95)55042-9 · Cited by 198
Regulation of cellular response to oncogenic and oxidative stress by Seladin-1
Wu, C., Miloslavskaya, I., Demontis, S., Maestro, R., & Galaktionov, K. (2004) · Nature · doi:10.1038/nature03173 · Cited by 192
“a,b, Western blot (WB) analysis; a, WI38-TERT/pBABEpuro and WI38-TERT/pBABEpuroSeladin-1si cells with (+) or without (2) ectopic Ha-RasV12 (Ras) transduction by WZLneoRasV12 retrovirus; b, Expression analysis of p53 and Seladin-1 in whole cell”
MethodInfluentialSelective Inhibition of Ras-dependent Cell Growth by Farnesylthiosalisylic Acid
Marom, M., Haklai, R., Ben-Baruch, G., Marciano, D., Egozi, Y., & Kloog, Y. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22263 · Cited by 193
Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation
Deschênes-Simard, X., Gaumont-Leclerc, M.-F., Bourdeau, V., Lessard, F., Moiseeva, O., Forest, V., Igelmann, S., Mallette, F. A., Saba-El-Leil, M. K., Meloche, S., et al. (2013) · Genes & Development · doi:10.1101/gad.203984.112 · Cited by 194
Retroviral insertional mutagenesis as a strategy to identify cancer genes
Jonkers, J., & Berns, A. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(95)00020-g · Cited by 194
(1987) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60793-9 · Cited by 196
Existence of High Abundance Antiproliferative mRNA's in Senescent Human Diploid Fibroblasts
Lumpkin, C. K., McClung, J. K., Pereira-Smith, O. M., & Smith, J. R. (1986) · Science · doi:10.1126/science.2421407 · Cited by 194
Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression
O'Hagan, R. C., Ohh, M., David, G., de Alboran, I. M., Alt, F. W., Kaelin, W. G., & DePinho, R. A. (2000) · Genes & Development · doi:10.1101/gad.827200 · Cited by 194
Primary Rat Embryo Cells Transformed by One or Two Oncogenes Show Different Metastatic Potentials
Pozzatti, R., Muschel, R., Williams, J., Padmanabhan, R., Howard, B., Liotta, L., & Khoury, G. (1986) · Science · doi:10.1126/science.3456644 · Cited by 196
Epidermal growth factor and its receptor
Gill, G. N., Bertics, P. J., & Santon, J. B. (1987) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(87)90027-x · Cited by 195
Transformation of Human Bronchial Epithelial Cells Transfected by Harvey ras Oncogene
Yoakum, G. H., Lechner, J. F., Gabrielson, E. W., Korba, B. E., Malan-Shibley, L., Willey, J. C., Valerio, M. G., Shamsuddin, A. M., Trump, B. F., & Harris, C. C. (1985) · Science · doi:10.1126/science.3975607 · Cited by 192
Ras proteins in the control of the cell cycle and cell differentiation
Crespo, P., & León, J. (2000) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000645 · Cited by 189
Isolation and characterization of a cloned growth factor dependent macrophage cell line, BAC1.2F5
Morgan, C., Pollard, J. W., & Stanley, E. R. (1987) · Journal of Cellular Physiology · doi:10.1002/jcp.1041300316 · Cited by 196
The c-myc proto-oncogene regulates cardiac development in transgenic mice.
Jackson, T., Allard, M. F., Sreenan, C. M., Doss, L. K., Bishop, S. P., & Swain, J. L. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.7.3709 · Cited by 186
Persson, H., Hennighausen, L., Taub, R., DeGrado, W., & Leder, P. (1984) · Science · doi:10.1126/science.6431612 · Cited by 197
MYC Instructs and Maintains Pancreatic Adenocarcinoma Phenotype
Sodir, N. M., Kortlever, R. M., Barthet, V. J. A., Campos, T., Pellegrinet, L., Kupczak, S., Anastasiou, P., Swigart, L. B., Soucek, L., Arends, M. J., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0435 · Cited by 182
Deng, Q., Liao, R., Wu, B.-L., & Sun, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308644200 · Cited by 181
Schneider, J. F., Fisher, F., Goding, C. R., & Jones, N. C. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02470.x · Cited by 190
KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism
Vaseva, A. V., Blake, D. R., Gilbert, T. S. K., Ng, S., Hostetter, G., Azam, S. H., Ozkan-Dagliyan, I., Gautam, P., Bryant, K. L., Pearce, K. H., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.10.001 · Cited by 187
“Growth transformation of rodent fibroblasts by mutant HRAS was shown long ago to require cooperating MYC overexpression, thereby providing the first demonstration that MYC can facilitate RAS-mediated oncogenesis (Land et al., 1983).”
BackgroundMYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma
Lu, Y., Yang, Q., Su, Y., Ji, Y., Li, G., Yang, X., Xu, L., Lu, Z., Dong, J., Wu, Y., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03790-w · Cited by 180
Coupling of Cell Growth Control and Apoptosis Functions of Id Proteins
Norton, J. D., & Atherton, G. T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2371 · Cited by 187
Principles and Strategies for Developing Network Models in Cancer
Pe'er, D., & Hacohen, N. (2011) · Cell · doi:10.1016/j.cell.2011.03.001 · Cited by 182
Lessons in Signaling and Tumorigenesis from Polyomavirus Middle T Antigen
Fluck, M. M., & Schaffhausen, B. S. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00009-09 · Cited by 179
Hanahan, D., Wagner, E. F., & Palmiter, R. D. (2007) · Genes & Development · doi:10.1101/gad.1583307 · Cited by 174
“They went on to demonstrate “oncogene cooperation” of Ras and Myc, a result initially demonstrated in transfected cells (Land et al. 1983), by crossing the MMTV-Myc and MMTV-v-HaRas mice.”
BackgroundThe HL60 cell line: a model system for studying human myeloid cell differentiation.
Birnie, G. D. (1988) · Europe PMC (PubMed Central) · Cited by 185
Hurlin, P. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.24.7019 · Cited by 184
“We used the Myc Ras cotransformation assay (Land et al., 1983) as a system to determine whether Mga expression influences the oncogenic activities of Myc.”
MethodOncogenic potential of bcl-2 demonstrated by gene transfer
Reed, J. C., Cuddy, M., Slabiak, T., Croce, C. M., & Nowell, P. C. (1988) · Nature · doi:10.1038/336259a0 · Cited by 180
Ferguson, B., Krippl, B., Andrisani, O., Jones, N., Westphal, H., & Rosenberg, M. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.10.2653 · Cited by 191
“The ElA and myc gene products appear to share certain structural (43) and functional similarities (30, 32, 46), and both proteins are predominantly nucleus localized (1, 14, 21, 31, 42, 59).”
BackgroundKeath, E. J., Caimi, P. G., & Cole, M. D. (1984) · Cell · doi:10.1016/0092-8674(84)90012-6 · Cited by 201
Estep, A. L., Tidyman, W. E., Teitell, M. A., Cotter, P. D., & Rauen, K. A. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31078 · Cited by 180
Quantitative proteomic analysis of Myc oncoprotein function
Shiio, Y., Donohoe, S., Yi, E. C., Goodlett, D. R., Aebersold, R., & Eisenman, R. N. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf525 · Cited by 184
Aging-Induced Stem Cell Mutations as Drivers for Disease and Cancer
Adams, P. D., Jasper, H., & Rudolph, K. L. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.05.002 · Cited by 180
“This evidence includes epidemiological modeling data (Armitage and Doll, 1954), in vitro cell transformation studies (Hahn et al., 1999; Land et al., 1983), analysis of hereditary cancer predisposition syndromes (Knudson, 1971), molecular pathology of cancer progression (Kinzler and Vogelstein,…”
BackgroundMethodNew Myc-interacting proteins: a second Myc network emerges
Sakamuro, D., & Prendergast, G. C. (1999) · Oncogene · doi:10.1038/sj.onc.1202725 · Cited by 177
“Consistent with physiological interaction, YY-1 was shown recently to inhibit Myc/Ras cotransformation (Austen et al., 1998).”
InfluentialSenescence Regulation by the p53 Protein Family
Qian, Y., & Chen, X. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_3 · Cited by 171
Grand, R. J. A., & Owen, D. (1991) · Biochemical Journal · doi:10.1042/bj2790609 · Cited by 181
The protein encoded by the human proto-oncogene c-myc.
Ramsay, G., Evan, G. I., & Bishop, J. M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7742 · Cited by 194
Suri, C., Fung, B., Tischler, A., & Chikaraishi, D. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-03-01280.1993 · Cited by 183
Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine.
Pisano, C., Pratesi, G., Laccabue, D., Zunino, F., Giudice, P. L., Bellucci, A., Pacifici, L., Camerini, B., Vesci, L., Castorina, M., et al. (2003) · PubMed · Cited by 202
Morice, W. G., Brunn, G. J., Wiederrecht, G., Siekierka, J. J., & Abraham, R. T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53755-8 · Cited by 180
Maya-Mendoza, A., Ostrakova, J., Kosar, M., Hall, A., Duskova, P., Mistrik, M., Merchut-Maya, J. M., Hodny, Z., Bartkova, J., Christensen, C., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2014.11.001 · Cited by 176
“…in addition to Ras also requires Myc overexpression or introduction of viral oncoproteins such as the SV40 small T antigen or E1A, which stabilizeMyc by inhibition of PP2A or FBW7, respectively (Land et al., 1983; Hahn et al., 2002; Seger et al., 2002; Yeh et al., 2004; Isobe et al., 2009).”
BackgroundMyc oncogenes: the enigmatic family
RYAN, K. M., & BIRNIE, G. D. (1996) · Biochemical Journal · doi:10.1042/bj3140713 · Cited by 175
The Regulation and Expression of c-myc in Normal and Malignant Cells
Kelly, K. (1986) · Annual Review of Immunology · doi:10.1146/annurev.immunol.4.1.317 · Cited by 184
Le, D. T., Kong, N., Zhu, Y., Lauchle, J. O., Aiyigari, A., Braun, B. S., Wang, E., Kogan, S. C., Le Beau, M. M., Parada, L., et al. (2004) · Blood · doi:10.1182/blood-2003-08-2650 · Cited by 175
Self-citationGenetic pathways in colorectal and other cancers
Ilyas, M., Straub, J., Tomlinson, I. P. M., & Bodmer, W. F. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00298-1 · Cited by 174
C-myc and c-fos in Human Osteosarcoma: Prognostic Value of mRNA and Protein Expression
Gamberi, G., Benassi, M. S., Bohling, T., Ragazzini, P., Molendini, L., Sollazzo, M. R., Pompetti, F., Merli, M., Magagnoli, G., Balladelli, A., et al. (1998) · Oncology · doi:10.1159/000011912 · Cited by 179
Jat, P. S., Cepko, C. L., Mulligan, R. C., & Sharp, P. A. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.4.1204 · Cited by 179
Clurman, B. E., & Hayward, W. S. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.6.2657 · Cited by 179
“The above in vivo observations are consistent with tissue culture experiments in which the activated mvc gene demonstrates only limited ability to transform primary embryo fibroblasts, except when cells are cotransfected with a second cooperating oncogene (15, 26).”
BackgroundAberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma.
Alitalo, K., Winqvist, R., Lin, C. C., de la Chapelle, A., Schwab, M., & Bishop, J. M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.14.4534 · Cited by 180
Contributions of Myc to tumorigenesis
Lutz, W., Leon, J., & Eilers, M. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00036-7 · Cited by 177
Fleming, J. B., Shen, G.-L., Holloway, S. E., Davis, M., & Brekken, R. A. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0206 · Cited by 176
“The synergy between the c-myc and ras pathways in malignant transformation of epithelial cells has been noted previously (31-33).”
BackgroundMercer, K., Giblett, S., Green, S., Lloyd, D., DaRocha Dias, S., Plumb, M., Marais, R., & Pritchard, C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2211 · Cited by 179
“Classic studies have previously established a requirement for oncogene cooperation in transformation of primary cells (38).”
Proliferation and invasion: Plasticity in tumor cells
Gao, C.-F., Xie, Q., Su, Y.-L., Koeman, J., Khoo, S. K., Gustafson, M., Knudsen, B. S., Hay, R., Shinomiya, N., & Woude, G. F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504367102 · Cited by 175
Determination of the c-MYC DNA-binding site.
Halazonetis, T. D., & Kandil, A. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6162 · Cited by 173
The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc.
Lugo, T. G., & Witte, O. N. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.3.1263 · Cited by 172
Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53.
Harlow, E., Williamson, N. M., Ralston, R., Helfman, D. M., & Adams, T. E. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.7.1601 · Cited by 174
Activated Proto-onc Genes: Sufficient or Necessary for Cancer?
Duesberg, P. H. (1985) · Science · doi:10.1126/science.3992240 · Cited by 179
Miltenberger, R. J., Sukow, K. A., & Farnham, P. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2527 · Cited by 172
“Both contribute to the transformation of primary rat embryo fibroblasts when overexpressed in culture (40, 61).”
BackgroundWyllie, A., Rose, K., Morris, R., Steel, C., Foster, E., & Spandidos, D. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.186 · Cited by 173
“Hence the generalisation that tumorigenicity requires co-activation of complementary oncogene groups (Land et al., 1983; Ruley, 1983; Weinberg, 1985) may apply even to cells transfected with single extraneous oncogenes.”
BackgroundNucleotide sequence of the human N-myc gene.
Stanton, L. W., Schwab, M., & Bishop, J. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1772 · Cited by 187
Sharpless, N. E., Ferguson, D. O., O'Hagan, R. C., Castrillon, D. H., Lee, C., Farazi, P. A., Alson, S., Fleming, J., Morton, C. C., Frank, K., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00425-7 · Cited by 175
Karnitz, L., Sutor, S. L., Torigoe, T., Reed, J. C., Bell, M. P., McKean, D. J., Leibson, P. J., & Abraham, R. T. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.10.4521 · Cited by 172
Magnaldo, I., L'Allemain, G., Chambard, J. C., Moenner, M., Barritault, D., & Pouysségur, J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75976-6 · Cited by 176
Tumor suppressor genes: the p53 and retinoblastoma sensitivity genes and gene products
Levine, A. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(90)90015-s · Cited by 173
Lazaris-Karatzas, A., & Sonenberg, N. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.1234 · Cited by 168
The c ‐ erbB ‐ 2 proto‐oncogene in human pancreatic cancer
Hall, P. A., Hughes, C. M., Staddon, S. L., Richman, P. I., Gullick, W. J., & Lemoine, N. R. (1990) · The Journal of Pathology · doi:10.1002/path.1711610305 · Cited by 171
Emergentism as a default: Cancer as a problem of tissue organization
Soto, A. M., & Sonnenschein, C. (2005) · Journal of Biosciences · doi:10.1007/bf02705155 · Cited by 166
“At the beginning of several course cor rections to come, at least two oncogenes were r equired ( Land et al 1983 ).”
BackgroundTransformation of Human and Murine Fibroblasts without Viral Oncoproteins
Boehm, J. S., Hession, M. T., Bulmer, S. E., & Hahn, W. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6464-6474.2005 · Cited by 171
“For example, the introduction of cooperating pairs of oncogenes such as the adenoviral E1A protein and an activated allele of H-RAS (RAS) or c-Myc (Myc) and RAS suffices to transform rodent cells (27, 42).”
BackgroundMice bearing the E mu-myc and E mu-pim-1 transgenes develop pre-B-cell leukemia prenatally.
Verbeek, S., van Lohuizen, M., van der Valk, M., Domen, J., Kraal, G., & Berns, A. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.2.1176 · Cited by 169
Shirakata, Y., Kawada, M., Fujiki, Y., Sano, H., Oda, M., Yaginuma, K., Kobayashi, M., & Koike, K. (1989) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1989.tb01686.x · Cited by 170
The protein products of the myc and myb oncogenes and adenovirus E1a are structurally related
Ralston, R., & Bishop, J. M. (1983) · Nature · doi:10.1038/306803a0 · Cited by 173
The cellular oncogene p53 can be activated by mutagenesis
Jenkins, J. R., Rudge, K., Chumakov, P., & Currie, G. A. (1985) · Nature · doi:10.1038/317816a0 · Cited by 169
Ras-MAPK signaling promotes trophectoderm formation from embryonic stem cells and mouse embryos
Lu, C.-W., Yabuuchi, A., Chen, L., Viswanathan, S., Kim, K., & Daley, G. Q. (2008) · Nature Genetics · doi:10.1038/ng.173 · Cited by 164
“We originally set out to test the hypothesis that expression of an activated Ras gene might complement Myc and telomerase function to induce malignant transformation in ES cells, in agreement with classical oncogene cooperation model”
Suppressor of Cytokine Signaling-1 Inhibits VAV Function through Protein Degradation
De Sepulveda, P., Ilangumaran, S., & Rottapel, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000106200 · Cited by 167
Analysis of the gene coding for the murine cellular tumour antigen p53.
Bienz, B., Zakut-Houri, R., Givol, D., & Oren, M. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02110.x · Cited by 167
Todokoro, K., Watson, R. J., Higo, H., Amanuma, H., Kuramochi, S., Yanagisawa, H., & Ikawa, Y. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.8900 · Cited by 176
Rane, S. G., Cosenza, S. C., Mettus, R. V., & Reddy, E. P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.644-656.2002 · Cited by 167
“Deregulation of cell proliferation leading to neoplastic transformation in primary rodent cells requires the expression of two cooperating oncogenes (24).”
BackgroundMyc versus USF: Discrimination at the cad Gene Is Determined by Core Promoter Elements
Boyd, K. E., & Farnham, P. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2529 · Cited by 167
“In accordance with this role, overexpression of c-myc contributes to the transformation of primary fibroblasts in culture (34) as well as to the development of neoplasia in a wide variety of tissues (for a review, see reference 39).”
BackgroundN-myc can cooperate with ras to transform normal cells in culture.
Yancopoulos, G. D., Nisen, P. D., Tesfaye, A., Kohl, N. E., Goldfarb, M. P., & Alt, F. W. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.16.5455 · Cited by 184
Oncogenes, ions, and phospholipids
Macara, I. G. (1985) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1985.248.1.c3 · Cited by 168
Franza, B. R., Maruyama, K., Garrels, J. I., & Ruley, H. E. (1986) · Cell · doi:10.1016/0092-8674(86)90462-9 · Cited by 166
Mammalian MYC Proteins and Cancer
Tansey, W. P. (2014) · New Journal of Science · doi:10.1155/2014/757534 · Cited by 151
Tang, Y., Horikawa, I., Ajiro, M., Robles, A. I., Fujita, K., Mondal, A. M., Stauffer, J. K., Zheng, Z.-M., & Harris, C. C. (2013) · Oncogene · doi:10.1038/onc.2012.288 · Cited by 165
Molecular Biology of Friend Viral Erythroleukemia
Kabat, D. (1989) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-74700-7_1 · Cited by 164
Interactions between Ras1, dMyc, and dPI3K signaling in the developing Drosophila wing
Prober, D. A., & Edgar, B. A. (2002) · Genes & Development · doi:10.1101/gad.991102 · Cited by 164
“Furthermore, the ability of RasV12 to deregulate cell identity and adhesion may underlie the strong synergy between Ras and other growth-promoting oncogenes in vivo (Land et al. 1983; Sinn et al. 1987).”
BackgroundQyang, Y., Luo, X., Lu, T., Ismail, P. M., Krylov, D., Vinson, C., & Sawadogo, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1508 · Cited by 160
“An autoradiogram from a representative experiment is shown, with quantitation indicated below each lane as the ratio of CAT activity observed in each case to the basal level observed with Ga14(1-147) alone.”
BackgroundMethodInfluentialMesenchymal cells reactivate Snail1 expression to drive three-dimensional invasion programs
Rowe, R. G., Li, X.-Y., Hu, Y., Saunders, T. L., Virtanen, I., de Herreros, A. G., Becker, K.-F., Ingvarsen, S., Engelholm, L. H., Bommer, G. T., et al. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200810113 · Cited by 161
“Snail1 conditional knockout transformed fi broblasts were generated by isolating embryonic day 13.5 mouse embryonic fi broblasts followed by serial retroviral introduction of the polyoma large T and activated Ras oncogenes ( Land et al., 1983 ).”
InfluentialCellular Response to Oncogenic Ras Involves Induction of the Cdk4 and Cdk6 Inhibitor p15INK4b
Malumbres, M., Pérez De Castro, I., Hernández, M. I., Jiménez, M., Corral, T., & Pellicer, A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2915-2925.2000 · Cited by 153
“Early on, transformation of primary cells was observed to require two cooperating oncogenes to convert normal cells to a tumorigenic state (27, 59).”
Background
Metadata
- Authors
- Land, H., Parada, L. F., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Venue
- Nature
- Published
- 1983-08
- Volume
- 304
- Issue
- 5927
- Pages
- 596-602
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1989009382
- Cited by
- 2,804
- References
- 56
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 22 · 2023: 15 · 2022: 17 · 2021: 24 · 2020: 22 · 2019: 36 · 2018: 17 · 2017: 23 · 2016: 24 · 2015: 39 · 2014: 27 · 2013: 30 · 2012: 37
- FWCI
- 96.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- embryonic fibroblasts, oncogene cooperation, oncogenic Ras, MYC gene, polyomavirus large T antigen, cell immortalization, transfection
- MeSH terms
- Animals, Antigens, Viral, Antigens, Viral, Tumor, Cell Line, Cell Transformation, Viral, Cells, Cultured, Fibroblasts, Gene Expression Regulation, Genes, Viral, Genetic Complementation Test, Oncogenes, Phenotype, Polyomavirus, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.